Current trials using bone-targeting agents in prostate cancer.

Tu, Shi-Ming; Lin, Sue-Hwa

Tu, Shi-Ming; Lin, Sue-Hwa.

Affiliation

Tu SM; Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. stu@mdanderson.org

Cancer J ; 14(1): 35-9, 2008.

Article in En | MEDLINE | ID: mdl-18303481

Subject(s)

Antineoplastic Agents/therapeutic use; Bone Neoplasms/drug therapy; Bone Neoplasms/secondary; Osteoblasts/drug effects; Osteoclasts/drug effects; Prostatic Neoplasms/drug therapy; Angiogenesis Inhibitors/therapeutic use; Antineoplastic Agents/pharmacology; Clinical Trials as Topic; Diphosphonates/pharmacology; Endothelin-1/drug effects; Humans; Male; Platelet-Derived Growth Factor/drug effects; Prostatic Neoplasms/pathology; Prostatic Neoplasms/physiopathology; Radiopharmaceuticals; Receptors, CXCR4/drug effects; Somatomedins/drug effects; Vitamin D/analogs & derivatives

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Osteoclasts / Prostatic Neoplasms / Bone Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Cancer J Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google